Dyslipidemias
374
42
60
221
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
43 trials with published results (11%)
Research Maturity
221 completed trials (59% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.7%
10 terminated out of 374 trials
95.7%
+9.1% vs benchmark
20%
74 trials in Phase 3/4
19%
43 of 221 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 221 completed trials
Clinical Trials (374)
Culturally Adapted Dietary Clinical Trial in PR
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
Military Health and Nutrition Examination Study
The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes
Effects of a Digital Health Application (Lipodia) on LDL-cholesterol Levels
Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial
Effect of Aerobic Training on the Health Parameters of Postmenopausal Women With Multimorbidity
Taiwanese Green Propolis for Lipid Profiles, Fatigue, and Quality of Life in Oral Cavity Cancer Survivors
Uppsala Self-Screening of Cardiovascular Health
Nudging Preventive Screening Via Message Framing and Bundling
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
Generative AI for Medication Counselling and Adherence in Community Pharmacies
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MWX205
Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia
Study of ARO-APOC3 in Adults With Dyslipidemia
Effects of Phytosterol Supplementation on Liver Function and Inflammatory Status in Patients With Nonalcoholic Fatty Liver Disease
Psychosocial, Environmental, and Chronic Disease Trends in Puerto Rico
Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
Impact of Phytosterol-Rich Extract on Lipid Profile
Cottonseed Oil Dose Response